110 related articles for article (PubMed ID: 3348170)
1. Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects.
Nakhleh R; Vogt JM; Edson JR
Am J Clin Pathol; 1988 Mar; 89(3):353-8. PubMed ID: 3348170
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
3. Use of purified dermatan sulfate for heparin cofactor II (HC II) assay.
Ruzzenente O; Ghidini R; Poli G; Schiavon R; Guidi GC
Thromb Res; 1992 Jan; 65(2):281-7. PubMed ID: 1579900
[TBL] [Abstract][Full Text] [Related]
4. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
[TBL] [Abstract][Full Text] [Related]
5. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
6. Heparin cofactor II: a simple assay method and results of its clinical application.
Vinazzer H; Pangraz U
Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
[TBL] [Abstract][Full Text] [Related]
7. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
Simmons RB; Newton GR; Doctor VM
Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
[TBL] [Abstract][Full Text] [Related]
8. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
9. Heparin cofactor II: experimental approach to a new assay and clinical results.
Vinazzer H; Stocker K
Thromb Res; 1991 Feb; 61(3):235-41. PubMed ID: 2028443
[TBL] [Abstract][Full Text] [Related]
10. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
11. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
[TBL] [Abstract][Full Text] [Related]
12. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
13. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of thrombin and chymotrypsin by heparin-cofactor II.
Struss D; Storck J; Zimmermann RE
Thromb Res; 1992 Oct; 68(1):45-56. PubMed ID: 1333106
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
Hurst RE; Poon MC; Griffith MJ
J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430
[TBL] [Abstract][Full Text] [Related]
17. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
Zhang G
Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin-III assay without influence of heparin cofactor II.
Enomoto M; Tanimizu I; Sakuragawa N
Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
[TBL] [Abstract][Full Text] [Related]
19. Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II.
Sié P; Petitou M; Lormeau JC; Dupouy D; Boneu B; Choay J
Biochim Biophys Acta; 1988 Aug; 966(2):188-95. PubMed ID: 3401503
[TBL] [Abstract][Full Text] [Related]
20. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
